Key statistics
On Friday, Neurogene Inc (NGNE:NMQ) closed at 17.23, 150.62% above the 52 week low of 6.88 set on Apr 08, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 16.87 |
|---|---|
| High | 17.46 |
| Low | 16.30 |
| Bid | 6.92 |
| Offer | 22.07 |
| Previous close | 16.37 |
| Average volume | 141.92k |
|---|---|
| Shares outstanding | 15.49m |
| Free float | 14.17m |
| P/E (TTM) | -- |
| Market cap | 253.57m USD |
| EPS (TTM) | -4.12 USD |
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
More ▼
- Neurogene to Participate in Upcoming Investor Conferences
- Neurogene Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Neurogene Announces Recent Achievements and Anticipated 2026 Key Milestones for NGN-401, a Potential Best-in-Class Gene Therapy for Rett Syndrome
- Neurogene to Participate in the 44th Annual J.P. Morgan Healthcare Conference
- Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Neurogene Reports Third Quarter 2025 Financial Results and Highlights Recent Updates
- Neurogene Reports Positive Interim Data in Pediatric Cohort from NGN-401 Gene Therapy Trial for Rett Syndrome
More ▼
